Discovery & Intelligence Services – Product Development Service

Whether you’re discovering novel bioactive compounds, validating ingredients, evaluating therapeutic pipelines, analyzing medical device materials, or entering new health markets, Pubrica’s Core Discovery & Intelligence Services transform scientific data into actionable insights.

Discovery and Intelligence Research Services for Product Development: Transforming Ideas into Market-Ready Solutions

Scientific Product Development and Research Gap Analyses

At Pubrica, we offer end-to-end scientific product development services driven by deep discovery and intelligence research to support pharmaceutical, biotechnology, nutraceutical, medical device, cosmeceuticals, herbal, pet health, life sciences, and healthcare organizations.

We built expertise in early-stage discovery, strategic thinking, and regulatory-compliant development, transforming clients’ innovative ideas into safe, effective, and market-ready products from concept to clinic and beyond. We provide primary and secondary research, competitive intelligence, biomarker discovery, medical device discovery services, continuing education, clinical trials, mechanism-of-action studies, pharmacological evaluation, and linked research papers to assure regulatory readiness and formulation suitability, chemical patent evaluation, biocompatibility ISO 10993, therapeutic landscapes, empowering R&D teams with data-driven insights to accelerate innovation and commercialization.

With a proven track record of delivering 1,000+ scientific research projects across pharmaceuticals, nutraceuticals, cosmeceuticals, biotech, herbal, and pet health domains, Pubrica stands as a trusted partner for evidence-driven discovery.

500+ subject matter experts in pharmacology, toxicology, clinical studies, and regulatory affairs
Experience in ingredient/compound intelligence, material compatibility, digital health platforms, biomarker identification, and chemical patent analysis
In-house capabilities to conduct primary and secondary research with access to worldwide clinical trial databases, peer-reviewed literature, and regulatory sources
Strong understanding of therapeutic landscapes, bioactive component validation, and formulation readiness
Support for validating concepts through regulatory-compliant discovery documentation

We bring the depth of scientific rigor and cross-functional expertise needed to guide your discovery process with precision and speed.

What We Do

Our Services – Discovery & Intelligence

At Pubrica, our Discovery & Intelligence Services aim to enhance innovation in all facets of pharmaceuticals, nutraceuticals, biotechnology, herbal, pet health, and medical devices. We provide a comprehensive service to R&D, regulatory, and product development teams to help uncover and confirm data-driven, evidence-based insights to develop drug candidates, raw materials, excipients, novel compounds, and bioactive ingredients.

Identification of Novel Compounds & Ingredients

Discovery of bioactive components, APIs, and natural actives using structured literature reviews, databases, and structure-activity relationship (SAR) analysis.

Chemical Patent Landscape Analysis

In-depth review of chemical patent documents, composition of matter claims, and freedom-to-operate (FTO) evaluations to support early-stage IP strategy.

Biomarker & Target Discovery

Identification of predictive biomarkers, therapeutic targets, and mechanism-of-action evidence to support drug repurposing and precision formulation.

Primary & Secondary Research

Collection of data from KOL interviews, scientific publications, clinical trials, and real-world evidence (RWE) to evaluate ingredient efficacy, safety, and innovation potential.

Raw Material & Source Intelligence

Sourcing insights for herbal extracts, functional ingredients, bioactive compounds, and rare actives, along with documentation on origin, purity, biological activity, and scientific justification.

Therapeutic Area Landscape Mapping

Competitive analysis and research gap assessment for disease areas of interest, helping teams align discovery pipelines with unmet clinical needs.

Patent & Intellectual Property (IP) Intelligence

We offer end-to-end support for innovation protection and competitive positioning, including:
• Prior Art Search
• Novelty/Patentability Search
• Validity/Invalidity Search
• Infringement Search
• State-of-the-Art Search
These services help our clients safeguard their product ideas, assess IP risks, and make informed decisions in early-stage R&D, especially for novel compounds, ingredients, or formulations.

PubMed Literature Review & Synthesis

Extraction and analysis of peer-reviewed studies for efficacy, safety, and biological justification of active ingredients or novel compounds.

Efficacy & Safety Profiling (Human and Preclinical Studies)

We conduct structured reviews of clinical trials, in vivo, and in vitro studies to assess the therapeutic efficacy and safety profile of bioactive compounds, APIs, and natural ingredients. This evidence supports claims substantiation and risk assessment for regulatory submissions.

Mechanism-of-Action (MOA) Research

Our experts analyze published literature and biochemical studies to uncover the mechanistic pathways through which a compound exerts its effect. This supports innovation positioning and is critical for precision formulation and biomarker alignment.

Pharmacological & Toxicological Evaluation

We compile data on pharmacodynamics, pharmacokinetics, and toxicology parameters for novel or existing ingredients to ensure safe dosing, bioavailability insights, and potential contraindications.

Disease Association & Therapeutic Positioning

We map ingredients or molecules to disease indications by reviewing epidemiological and clinical research, helping define therapeutic relevance, product differentiation, and unmet clinical needs.

Clinical Trial Landscape Mapping

Analyse ongoing and completed clinical trials from global registries (e.g., ClinicalTrials.gov, EUCTR) to:
• Benchmark competing compounds
• Understand trial design strategies
• Support go/no-go decisions
Used for: Drug repositioning, ingredient differentiation, trial planning

Competitive Product Benchmarking

Systematic comparison of formulations, actives, and claims across top competitors to guide:
• Product positioning
• Gap identification
• Innovation strategy

Claims Substantiation Research

Scientific justification for health, structure-function, and cosmetic claims using regulatory-compliant, peer-reviewed evidence. Important for: Labelling, advertising, legal risk reduction

GRAS/Novel Food/Herbal Monograph Support

Data collation to support Generally Recognized As Safe (GRAS) status, novel food applications, and herbal compendium inclusion (e.g., WHO, EFSA, AYUSH).

Regulatory Landscape Intelligence

Jurisdiction-specific reviews (FDA, EMA, FSSAI, EFSA, TGA, etc.) to understand:
• Ingredient restrictions
• Claim limitations
• Documentation requirements
Supports: Global product launch readiness

Scientific Writing & Publication Support

• White papers, monographs
• Regulatory briefs or substantiation reports
• Journal publications to support scientific credibility

Technology & Delivery System Scouting

Identify delivery innovations like nanocarriers, liposomes, or slow-release systems that enhance ingredient bioavailability or product performance.

Material Compatibility & Safety Assessment

Evaluation of materials (metals, polymers, coatings, biologics) used in devices for:
• Chemical compatibility with APIs or biological tissues
• Interaction risks (e.g., leachable, degradation products)
• Surface treatment effects on drug/device performance
Supports: Formulation selection, coating systems, and device performance

Biocompatibility Literature Review (ISO 10993)

Secondary research to assess toxicological and biological risks (cytotoxicity, irritation, sensitization, etc.) of device components, aligned with ISO 10993 series standards. Used for: Preclinical safety documentation, risk analysis, and regulatory submissions

Device-Drug Interaction Intelligence (for Combination Products)

Assessment of how active ingredients interact with device materials over time, including:
• Drug adsorption/loss from the container/packaging
• Impact of delivery mechanisms (e.g., pumps, patches, inhalers)
• Stability under storage and usage conditions

Regulatory Classification & Predicate Device Analysis

Assessments supporting legal cases involving mental health, fitness for duty, personal injury, or trauma disorders.

Clinical & Functional Use Case Mapping

Identifying and analysing clinical utility, end-user needs, and market gaps to guide:
• Feature design decisions
• Functional claim development
• Usability study planning

Who We Serve

At Pubrica, we provide Core Discovery & Intelligence Services to a diverse range of industries and organizations developing scientifically grounded, market-ready products. From early-stage research to regulatory-aligned discovery documentation, our services are tailored to meet the distinct R&D needs of each client segment.

Pharmaceutical Companies

Support for drug discovery, composition of matter analysis, biomarker identification, and scientific validation aligned with FDA, EMA, and ICMR requirements.

Nutraceutical & Dietary Supplement Companies

Discovery of bioactive ingredients, clinical literature review, ingredient sourcing, and compliance with FSSAI, FDA, and EFSA standards.

Food & Functional Beverage Manufacturers

Support for functional ingredient research, efficacy data collection, and regulatory evidence for novel foods and health claims.

Cosmetics & Personal Care Brands

Ingredient discovery, toxicology intelligence, and mechanism-of-action research to support skin, hair, and oral care formulations aligned with INCI, REACH, and safety assessment standards.

Medical Device Manufacturers

Scientific support for devices that incorporate biologically active materials, combination products, or require regulatory intelligence around material selection and biocompatibility.

Startups & Entrepreneurs

Support in identifying novel ingredients, clinical backing, and competitive intelligence for product concept validation and investor documentation.

Contract Research Organizations (CROs)

Scientific content development, target and compound validation, secondary research, and regulatory literature reviews to support sponsors and submissions.

Academic Institutions & Research Bodies

Collaboration on translational research, technology scouting, and ingredient or compound commercialization through evidence mapping and IP intelligence.

Cosmeceutical & Derma Companies

Scientific evaluation of active ingredients, dermatological evidence collection, and discovery of anti-aging, acne, and skin-repair compounds using clinical and preclinical data.

Pet Food & Veterinary Health Companies

Discovery of safe and effective bioactive herbs and functional ingredients for companion animal health, including clinical support for gut health, joint care, and immune support claims.

Biotechnology Companies

Early-stage discovery services, including gene/protein target validation, biomarker discovery, and mechanism insights to accelerate preclinical programs.

Whether you’re launching a novel compound or validating an existing ingredient, Pubrica’s Discovery & Intelligence Services are built to move you from research to regulatory-ready with clarity and scientific confidence.

The Industry Vertical We Serve

Pharmaceuticals

Biotechnology

Nutraceuticals & Dietary Supplements

Herbal/AYUSH products

Functional Foods & Beverages

Medical Devices

Cosmetics & Cosmeceuticals

Pet Health & Pet Food

Life Sciences & Healthcare Research

How Our Product Development Service Works

Our step-by-Step Process

At Pubrica, our Core Discovery & Intelligence Services support every stage of product development by delivering scientifically validated insights, starting from idea generation to regulatory-ready evidence. We use a rigorous, research-first approach that combines primary and secondary research, literature mining, patent intelligence, and clinical validation to ensure products are safe, effective, and market-ready.

Ideation & Conceptualization

We begin by understanding your product concept and strategic goals. Through market gap analysis, therapeutic landscape reviews, and competitive intelligence, we help identify high-potential opportunities grounded in unmet needs and innovation potential.

Research & Ingredient Intelligence

Using primary research (expert/KOL interviews, surveys) and secondary research (scientific publications, clinical trials, regulatory sources), we identify and evaluate bioactive ingredients, APIs, and novel compounds, validating their efficacy, safety, and relevance.

Literature & Patent Analysis

We conduct in-depth literature reviews and chemical patent analysis to assess prior art, freedom to operate (FTO), and novelty of proposed ingredients or formulations. This step supports strategic IP planning and regulatory risk reduction.

Scientific Validation & Evidence Building

We compile and synthesize supporting data from clinical studies, biological mechanism research, and toxicology evaluations to strengthen your product’s scientific foundation, enabling regulatory submissions and claims substantiation.

Go-to-Market Intelligence & Strategic Support

We provide insight into launch readiness, competitive positioning, and scientific differentiation, ensuring your product stands out with validated claims and a compelling evidence base.

Speed up your Product development with Pubrica

Pubrica’s Product Development Services provide end-to-end support, from concept ideation to market launch. We ensure scientifically backed formulations, regulatory compliance, and efficient manufacturing for successful product commercialization.

Our Compliance and Guideline Standards

At Pubrica, compliance is embedded into every aspect of our discovery and intelligence services. We follow globally recognized regulatory, ethical, and scientific standards to ensure that all our research outputs, whether for drugs, nutraceuticals, devices, food, or cosmetic products, are court-defensible, regulatory-aligned, and scientifically validated.

We Align With Regulatory Authorities Across Industries

Pharmaceuticals & Biotech

FDA (U.S. Food & Drug Administration)
EMA (European Medicines Agency)
ICMR (Indian Council of Medical Research)
MHRA (UK), TGA (Australia)
ICH Guidelines (E6 GCP, E9 Statistical Principles)

Nutraceuticals, Herbal & AYUSH

FSSAI (Food Safety & Standards Authority of India)
AYUSH Ministry (India)
EFSA (European Food Safety Authority)
USP Dietary Supplement Compendium
DSHEA (U.S. Dietary Supplement Health and Education Act)

Cosmetics & Cosmeceuticals

FDA (Cosmetic Regulations – U.S.)
EU Cosmetic Regulation (EC) No 1223/2009
REACH (for chemical ingredient safety)
INCI (International Nomenclature of Cosmetic Ingredients)

Functional Foods & Ingredients

GRAS (Generally Recognized As Safe – U.S.)
Novel Food Regulation (EU)
Codex Alimentarius
FSSAI Nutraceutical & Health Supplement Standards

Pet Food & Veterinary Health

AAFCO (Association of American Feed Control Officials)
FDA CVM (Center for Veterinary Medicine)
FEDIAF (European Pet Food Industry Federation)
APVMA (Australia) for animal products

Medical Devices

FDA 21 CFR Parts 820 (QSR)
EU MDR 2017/745 (Medical Device Regulation)
ISO 10993 (Biocompatibility)
IEC 62304 / ISO 14971 (Software, Risk Management)
510(k) & CE Marking Requirements

Scientific & Ethical
Guidelines

Good Clinical Practice (GCP – ICH E6)
Good Laboratory Practice (GLP – OECD)
Declaration of Helsinki
CONSORT, PRISMA, STROBE (for scientific publication standards)
OECD Guidelines for Toxicity & Safety Studies
PubMed, Cochrane, and WHO sources for literature evidence

Data Privacy & Confidentiality Compliance

HIPAA (U.S.) – Patient Data Protection
GDPR (EU) – General Data Protection Regulation
Indian IT Act & Data Protection Rules
ClinicalTrials.gov, EUCTR, CTRI transparency standards

Discovery & Intelligence Services Sample Work

Discover More

Download the full Report Now

Explore our Product Development service sample work, accurately designed to meet industry standards, comply with regulatory requirements, and deliver innovative, high-quality solutions that drive market success.

Discover More

Product Development Service – Our Packages

Our product development services offer end-to-end solutions, from concept ideation to market-ready products, tailored to meet industry standards and regulatory requirements. Our packages are designed to meet the specific research, validation, and regulatory intelligence needs of pharmaceutical, biotech, nutraceutical, herbal, cosmeceutical, pet health, medical device, and life science companies. Each tier delivers strategic support to accelerate your product’s path from discovery to market.

PubMed literature review (efficacy/safety)

Basic clinical trial mapping (relevant to compound/indication)

Ingredient/compound background report

1 therapeutic area overview

Preliminary regulatory guidance (FSSAI, FDA, EMA, etc.)

Patent landscape & novelty/prior art search

Safety, pharmacological & toxicological profile

Mechanism-of-action evidence mapping

Disease association & therapeutic positioning

Regulatory classification (GRAS, AYUSH, 510(k), etc.)

Full biomarker & pathway linkage analysis

Competitive product benchmarking

Regulatory landscape & dossier readiness report

Claims substantiation matrix

Drafting of white papers or regulatory briefs

Optional: Biocompatibility literature review (for medical devices)

Veterinary or pet food ingredient analysis

Cosmeceutical ingredient toxicity & INCI alignment

Combination product (drug-device) compatibility studies

Delivery system innovation mapping

Sustainability & sourcing intelligence

Post-market literature surveillance

All Packages Include:

Support from Pubrica’s 500+ domain experts
Reports aligned with global regulatory authorities (FDA, EMA, EFSA, FSSAI, AYUSH, etc.)
Scientifically defensible evidence based on Level A research, clinical trials, and validated databases

Testimonials

Our product development services offer expert support to businesses, entrepreneurs, and researchers by providing innovative solutions backed by industry standards. Here’s what some of our clients say:

"Pubrica’s scientific research team delivered a comprehensive literature and biomarker review that strengthened our regulatory submission in the EU. Their clinical evidence and mechanism-of-action research was impressive. "

— Elena Morris

Regulatory Affairs Manager, PharmaGenix, Germany

"We were impressed by Pubrica’s ability to translate complex clinical data into a clear, defensible claim strategy. Their work in patent analysis and ingredient mapping was key to our U.S. nutraceutical launch."

— Thomas Reynolds

Director of R&D, NutraCore Labs, USA

"As an herbal supplement company, we needed deep validation for our formulation. Pubrica’s team provided detailed secondary research, supported by regulatory-aligned insights from WHO and AYUSH sources."

— Rajesh Kumar

CEO, Nutraceutical Innovations, India

"Pubrica’s discovery insights into pet health ingredients, combined with their knowledge of AAFCO and FDA-CVM guidelines, helped us confidently position our new veterinary formula for the North American market."

— Sophie Grant

Product Strategy Lead, VetLife Science, Canada

"The scientific intelligence Pubrica delivered from therapeutic landscape mapping to regulatory pathway planning helped us fast-track early decisions for our oncology pipeline."

— Sanya Patel

Head of Translational Science, OncoTech Biologics, UK

"Pubrica's team provided exceptional support in finalizing my cross-sectional study on adolescent nutrition. Their attention to ethical standards and STROBE compliance helped secure acceptance in BMC Public Health without major revisions."

Dr. Anitha Raj,

Assistant Professor, India

"The scientific accuracy and journal-specific formatting were excellent. Pubrica structured the manuscript precisely to match the Journal of Translational Medicine submission format, especially in compliance with STROBE guidelines. This significantly accelerated the peer-review outcome.”

Prof. Markus Klein,

Biomedical Researcher, Germany flag

"Pubrica’s team demonstrated high-level scientific expertise in writing and structuring my oncology manuscript. Their adherence to CONSORT guidelines and formatting as per the Asian Pacific Journal of Cancer Prevention ensured quick peer acceptance. Highly recommended for clinicians aiming for an indexed publication.”

Dr. Sanjay Menon,

Clinical Oncologist, India

Frequently Asked Questions – Core Discovery & Intelligence Services

1. How do you ensure regulatory compliance during early product discovery?

We provide in-depth regulatory intelligence by reviewing region-specific guidelines from FSSAI, FDA, EMA, AYUSH, EFSA, and others. Our experts align discovery insights with the relevant regulatory frameworks, helping you understand ingredient restrictions, allowable claims, documentation requirements, and classification pathways (e.g., GRAS, novel food, 510(k)). This ensures that your product concept is regulatory-ready from the start.

2. How long does the discovery and intelligence phase typically take?

The timeline depends on the complexity of the research. A basic literature review or PubMed-based analysis may take 2–3 weeks. More comprehensive discovery projects involving biomarker mapping, patent searches, regulatory landscape reviews, or ingredient validation can take 6–10 weeks. Custom projects are scoped based on required depth and markets targeted.

3. Do you help with identifying the right active ingredients or bioactive?

Yes. Our team conducts primary and secondary research to identify clinically supported ingredients, bioactive compounds, or raw materials suitable for your indication or formulation goal. We evaluate evidence from clinical trials, toxicological data, and mechanism-of-action studies, supporting ingredient selection with scientific and regulatory justification.

4. What types of research do you conduct for nutraceuticals and functional foods?

We perform literature reviews, clinical trial mapping, claims substantiation, and regulatory classification analysis for ingredients used in nutraceuticals, functional foods, and dietary supplements. This helps you validate efficacy, understand disease associations, and ensure compliance with health claims guidelines from FSSAI, EFSA, FDA/DSHEA, and others.

5. Do you support medical devices or drug-device combinations during early discovery?

Yes. We provide material compatibility reviews, ISO 10993 biocompatibility literature analysis, and regulatory pathway insights for medical devices and combination products. We also assist in identifying predicate devices, conducting risk-based reviews, and assessing drug-device interactions for submission readiness.

6. Can you support scientific evidence generation for regulatory submissions?

Yes. We prepare scientific literature reviews, pharmacological and toxicological summaries, biomarker/pathway mappings, and regulatory briefs aligned with global authorities. These deliverables are suitable for dossier support, claims substantiation, and scientific communication in the context of market authorization or investment readiness.

Insights

Organize journal matching by different decision-making filters: